Gene Page: SH3KBP1
Summary ?
GeneID | 30011 |
Symbol | SH3KBP1 |
Synonyms | CD2BP3|CIN85|GIG10|HSB-1|HSB1|MIG18 |
Description | SH3-domain kinase binding protein 1 |
Reference | MIM:300374|HGNC:HGNC:13867|Ensembl:ENSG00000147010|HPRD:02301|Vega:OTTHUMG00000021227 |
Gene type | protein-coding |
Map location | Xp22.1-p21.3 |
Sherlock p-value | 0.057 |
Fetal beta | -0.887 |
Support | G2Cdb.human_BAYES-COLLINS-MOUSE-PSD-CONSENSUS G2Cdb.humanPSD G2Cdb.humanPSP Potential synaptic genes |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:GWASdb | Genome-wide Association Studies | GWASdb records for schizophrenia | |
CV:PGCnp | Genome-wide Association Study | GWAS | |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 1 | |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.2206 |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0003674 | molecular_function | ND | - | |
GO:0005515 | protein binding | IPI | 12029088 | |
GO:0017124 | SH3 domain binding | IEA | - | |
GO:0016301 | kinase activity | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0007267 | cell-cell signaling | NAS | 10679202 | |
GO:0006915 | apoptosis | IEA | - | |
GO:0006897 | endocytosis | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0019717 | synaptosome | IEA | Synap, Brain (GO term level: 7) | - |
GO:0045202 | synapse | IEA | neuron, Synap, Neurotransmitter, Glial (GO term level: 2) | - |
GO:0005829 | cytosol | EXP | 10567358 |11894095 |12218189 |15962011 | |
GO:0005856 | cytoskeleton | IEA | - | |
GO:0005634 | nucleus | IDA | 18029348 | |
GO:0005730 | nucleolus | IDA | 18029348 | |
GO:0005737 | cytoplasm | IEA | - | |
GO:0005886 | plasma membrane | EXP | 16407834 | |
GO:0030054 | cell junction | IEA | - | |
GO:0031410 | cytoplasmic vesicle | IEA | - | |
GO:0030659 | cytoplasmic vesicle membrane | IEA | - |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
ABI2 | ABI-2 | ABI2B | AIP-1 | AblBP3 | SSH3BP2 | argBPIA | argBPIB | abl interactor 2 | - | HPRD,BioGRID | 10858458 |
ARHGAP27 | CAMGAP1 | FLJ43547 | MGC120624 | Rho GTPase activating protein 27 | - | HPRD,BioGRID | 15147912 |
ASAP1 | AMAP1 | CENTB4 | DDEF1 | KIAA1249 | PAG2 | PAP | ZG14P | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | DDEF1 (AMAP1) interacts with SH3KBP1 (CIN85). | BIND | 15719014 |
ASAP2 | AMAP2 | CENTB3 | DDEF2 | FLJ42910 | KIAA0400 | PAG3 | PAP | Pap-alpha | SHAG1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | DDEF2 (AMAP2) interacts with SH3KBP1 (CIN85). | BIND | 15719014 |
BCAR1 | CAS | CAS1 | CASS1 | CRKAS | P130Cas | breast cancer anti-estrogen resistance 1 | Affinity Capture-Western | BioGRID | 11071869 |
BLNK | BASH | BLNK-S | LY57 | MGC111051 | SLP-65 | SLP65 | B-cell linker | - | HPRD,BioGRID | 11071869 |
CAPZA1 | CAPPA1 | CAPZ | CAZ1 | capping protein (actin filament) muscle Z-line, alpha 1 | - | HPRD | 12690097 |
CBL | C-CBL | CBL2 | RNF55 | Cas-Br-M (murine) ecotropic retroviral transforming sequence | - | HPRD,BioGRID | 11894095 |
CBL | C-CBL | CBL2 | RNF55 | Cas-Br-M (murine) ecotropic retroviral transforming sequence | CIN85 interacts with Cbl. | BIND | 11894095 |
CBLB | DKFZp686J10223 | DKFZp779A0729 | DKFZp779F1443 | FLJ36865 | FLJ41152 | Nbla00127 | RNF56 | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | - | HPRD,BioGRID | 12218189 |
CD2 | SRBC | T11 | CD2 molecule | - | HPRD | 12690097 |
CD2 | SRBC | T11 | CD2 molecule | - | HPRD,BioGRID | 9857189 |12690097|12690097 |
CD2 | SRBC | T11 | CD2 molecule | SETA interacts with CD2. This interaction was modelled on a demonstrated interaction between rat SETA and human CD2. | BIND | 11152963 |
CLYBL | CLB | bA134O15.1 | citrate lyase beta like | Affinity Capture-Western | BioGRID | 11894096 |
CRK | CRKII | v-crk sarcoma virus CT10 oncogene homolog (avian) | Affinity Capture-Western | BioGRID | 11071869 |
EGFR | ERBB | ERBB1 | HER1 | PIG61 | mENA | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | Affinity Capture-Western | BioGRID | 11894095 |12177062 |
GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | growth factor receptor-bound protein 2 | - | HPRD | 9507006|11152963 |
GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | growth factor receptor-bound protein 2 | SETA interacts with Grb2. This interaction was modelled on a demonstrated interaction between rat SETA and human Grb2 | BIND | 11152963 |
GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | growth factor receptor-bound protein 2 | Reconstituted Complex | BioGRID | 10921882 |11152963 |
KIT | C-Kit | CD117 | PBT | SCFR | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Affinity Capture-Western | BioGRID | 12177062 |
MET | AUTS9 | HGFR | RCCP2 | c-Met | met proto-oncogene (hepatocyte growth factor receptor) | - | HPRD,BioGRID | 11894096 |
NEDD4 | KIAA0093 | MGC176705 | NEDD4-1 | RPF1 | neural precursor cell expressed, developmentally down-regulated 4 | - | HPRD,BioGRID | 12218189 |
PAK2 | PAK65 | PAKgamma | p21 protein (Cdc42/Rac)-activated kinase 2 | - | HPRD,BioGRID | 12829691 |
PDCD6 | ALG-2 | FLJ46208 | MGC111017 | MGC119050 | MGC9123 | PEF1B | programmed cell death 6 | - | HPRD,BioGRID | 10858458 |
PDGFRB | CD140B | JTK12 | PDGF-R-beta | PDGFR | PDGFR1 | platelet-derived growth factor receptor, beta polypeptide | - | HPRD,BioGRID | 12177062 |
PIK3R1 | GRB1 | p85 | p85-ALPHA | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | - | HPRD,BioGRID | 10921882 |
SH3GL1 | CNSA1 | EEN | MGC111371 | SH3D2B | SH3P8 | SH3-domain GRB2-like 1 | Endophilin A2 interacts with CIN85. This interaction was modeled on a demonstrated interaction between endophilin A2 from an unspecified species and human CIN85. | BIND | 11894096 |
SH3GL2 | CNSA2 | EEN-B1 | FLJ20276 | FLJ25015 | SH3D2A | SH3P4 | SH3-domain GRB2-like 2 | - | HPRD,BioGRID | 12218189 |
SH3GL2 | CNSA2 | EEN-B1 | FLJ20276 | FLJ25015 | SH3D2A | SH3P4 | SH3-domain GRB2-like 2 | CIN85 interacts with endophilin A1. This interaction was modeled on a demonstrated interaction between human CIN85 and mouse endophilin A1. | BIND | 11894095 |
SH3GL3 | CNSA3 | EEN-2B-L3 | EEN-B2 | HsT19371 | SH3D2C | SH3P13 | SH3-domain GRB2-like 3 | Endophilin A3 interacts with CIN85. | BIND | 11894096 |
SH3GL3 | CNSA3 | EEN-2B-L3 | EEN-B2 | HsT19371 | SH3D2C | SH3P13 | SH3-domain GRB2-like 3 | Affinity Capture-Western Reconstituted Complex Two-hybrid | BioGRID | 11894096 |
SH3GLB1 | Bif-1 | CGI-61 | KIAA0491 | dJ612B15.2 | SH3-domain GRB2-like endophilin B1 | Reconstituted Complex | BioGRID | 11894096 |
SH3GLB2 | KIAA1848 | PP6569 | PP9455 | SH3-domain GRB2-like endophilin B2 | Reconstituted Complex Two-hybrid | BioGRID | 11894095 |11894096 |
SH3KBP1 | CIN85 | GIG10 | MIG18 | SH3-domain kinase binding protein 1 | Affinity Capture-Western Two-hybrid | BioGRID | 11071869 |11894095 |
SHKBP1 | PP203 | Sb1 | SH3KBP1 binding protein 1 | - | HPRD,BioGRID | 11152963 |
SOS1 | GF1 | GGF1 | GINGF | HGF | NS4 | son of sevenless homolog 1 (Drosophila) | - | HPRD,BioGRID | 11071869 |
SYNJ1 | INPP5G | synaptojanin 1 | Affinity Capture-Western Far Western | BioGRID | 12829691 |
TAF6 | DKFZp781E21155 | MGC:8964 | TAF2E | TAFII70 | TAFII80 | TAFII85 | TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa | - | HPRD,BioGRID | 12829691 |
TJP2 | MGC26306 | X104 | ZO-2 | ZO2 | tight junction protein 2 (zona occludens 2) | - | HPRD,BioGRID | 12829691 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG ENDOCYTOSIS | 183 | 132 | All SZGR 2.0 genes in this pathway |
BIOCARTA CBL PATHWAY | 13 | 10 | All SZGR 2.0 genes in this pathway |
PID MET PATHWAY | 80 | 60 | All SZGR 2.0 genes in this pathway |
PID ERBB1 INTERNALIZATION PATHWAY | 41 | 35 | All SZGR 2.0 genes in this pathway |
REACTOME SIGNALING BY EGFR IN CANCER | 109 | 80 | All SZGR 2.0 genes in this pathway |
REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | 29 | 24 | All SZGR 2.0 genes in this pathway |
REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | 126 | 90 | All SZGR 2.0 genes in this pathway |
REACTOME EGFR DOWNREGULATION | 25 | 14 | All SZGR 2.0 genes in this pathway |
REACTOME IMMUNE SYSTEM | 933 | 616 | All SZGR 2.0 genes in this pathway |
REACTOME ADAPTIVE IMMUNE SYSTEM | 539 | 350 | All SZGR 2.0 genes in this pathway |
CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP | 146 | 86 | All SZGR 2.0 genes in this pathway |
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP | 579 | 346 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN | 455 | 304 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN | 460 | 312 | All SZGR 2.0 genes in this pathway |
HORIUCHI WTAP TARGETS UP | 306 | 188 | All SZGR 2.0 genes in this pathway |
WAMUNYOKOLI OVARIAN CANCER LMP UP | 265 | 158 | All SZGR 2.0 genes in this pathway |
CHEBOTAEV GR TARGETS DN | 120 | 73 | All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER CLUSTER 1 DN | 378 | 231 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY SERUM DEPRIVATION DN | 234 | 147 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | All SZGR 2.0 genes in this pathway |
GAUSSMANN MLL AF4 FUSION TARGETS A UP | 191 | 128 | All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER CLUSTER 2B | 392 | 251 | All SZGR 2.0 genes in this pathway |
SCHAEFFER PROSTATE DEVELOPMENT 48HR DN | 428 | 306 | All SZGR 2.0 genes in this pathway |
PASQUALUCCI LYMPHOMA BY GC STAGE DN | 165 | 104 | All SZGR 2.0 genes in this pathway |
XU GH1 AUTOCRINE TARGETS UP | 268 | 157 | All SZGR 2.0 genes in this pathway |
ZHENG BOUND BY FOXP3 | 491 | 310 | All SZGR 2.0 genes in this pathway |
MARTINEZ RB1 TARGETS UP | 673 | 430 | All SZGR 2.0 genes in this pathway |
MARTINEZ TP53 TARGETS UP | 602 | 364 | All SZGR 2.0 genes in this pathway |
MARTINEZ RB1 AND TP53 TARGETS UP | 601 | 369 | All SZGR 2.0 genes in this pathway |
SARRIO EPITHELIAL MESENCHYMAL TRANSITION UP | 180 | 114 | All SZGR 2.0 genes in this pathway |
IZADPANAH STEM CELL ADIPOSE VS BONE UP | 126 | 92 | All SZGR 2.0 genes in this pathway |
HUANG DASATINIB RESISTANCE UP | 81 | 53 | All SZGR 2.0 genes in this pathway |
YOSHIMURA MAPK8 TARGETS UP | 1305 | 895 | All SZGR 2.0 genes in this pathway |
ROME INSULIN TARGETS IN MUSCLE UP | 442 | 263 | All SZGR 2.0 genes in this pathway |
MIKKELSEN MCV6 LCP WITH H3K4ME3 | 162 | 80 | All SZGR 2.0 genes in this pathway |
MIKKELSEN MEF LCP WITH H3K4ME3 | 128 | 68 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS DN | 1972 | 1213 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE VIA TP53 GROUP A | 898 | 516 | All SZGR 2.0 genes in this pathway |
MIYAGAWA TARGETS OF EWSR1 ETS FUSIONS UP | 259 | 159 | All SZGR 2.0 genes in this pathway |
HUANG GATA2 TARGETS UP | 149 | 96 | All SZGR 2.0 genes in this pathway |
ACEVEDO FGFR1 TARGETS IN PROSTATE CANCER MODEL UP | 289 | 184 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-124/506 | 639 | 645 | m8 | hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA |
hsa-miR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
miR-129-5p | 977 | 983 | m8 | hsa-miR-129brain | CUUUUUGCGGUCUGGGCUUGC |
hsa-miR-129-5p | CUUUUUGCGGUCUGGGCUUGCU | ||||
miR-142-5p | 362 | 368 | 1A | hsa-miR-142-5p | CAUAAAGUAGAAAGCACUAC |
miR-153 | 509 | 515 | 1A | hsa-miR-153 | UUGCAUAGUCACAAAAGUGA |
miR-182 | 79 | 85 | 1A | hsa-miR-182 | UUUGGCAAUGGUAGAACUCACA |
miR-218 | 144 | 150 | 1A | hsa-miR-218brain | UUGUGCUUGAUCUAACCAUGU |
miR-22 | 681 | 687 | 1A | hsa-miR-22brain | AAGCUGCCAGUUGAAGAACUGU |
miR-26 | 2 | 8 | m8 | hsa-miR-26abrain | UUCAAGUAAUCCAGGAUAGGC |
hsa-miR-26bSZ | UUCAAGUAAUUCAGGAUAGGUU | ||||
miR-33 | 997 | 1003 | 1A | hsa-miR-33 | GUGCAUUGUAGUUGCAUUG |
hsa-miR-33b | GUGCAUUGCUGUUGCAUUGCA | ||||
miR-410 | 579 | 585 | 1A | hsa-miR-410 | AAUAUAACACAGAUGGCCUGU |
miR-448 | 962 | 968 | m8 | hsa-miR-448 | UUGCAUAUGUAGGAUGUCCCAU |
hsa-miR-448 | UUGCAUAUGUAGGAUGUCCCAU | ||||
miR-450 | 977 | 983 | 1A | hsa-miR-450 | UUUUUGCGAUGUGUUCCUAAUA |
miR-542-3p | 394 | 400 | 1A | hsa-miR-542-3p | UGUGACAGAUUGAUAACUGAAA |
miR-96 | 78 | 85 | 1A,m8 | hsa-miR-96brain | UUUGGCACUAGCACAUUUUUGC |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.